A new promoter allows optogenetic vision restoration with enhanced sensitivity in macaque retina

Archive ouverte

Chaffiol, Antoine | Caplette, Romain, P | Jaillard, Céline | Brazhnikova, Elena | Desrosiers, Mélissa | Dubus, Elisabeth | Duhamel, Laëtitia | Macé, Emilie | Marre, Olivier | Benoit, Patrick | Hantraye, Philippe | Bemelmans, Alexis-Pierre | Bamberg, Ernst | Duebel, Jens | Sahel, José-Alain | Picaud, Serge | Dalkara, Deniz

Edité par CCSD ; Cell Press -

International audience. The majority of inherited retinal degenerations converge on the phenotype of photoreceptor cell death. Second- and third-order neurons are spared in these diseases, making it possible to restore retinal light responses using optogenetics. Viral expression of channelrhodopsin in the third-order neurons under ubiquitous promoters was previously shown to restore visual function, albeit at light intensities above illumination safety thresholds. Here, we report (to our knowledge, for the first time) activation of macaque retinas, up to 6 months post-injection, using channelrhodopsin-Ca2+-permeable channelrhodopsin (CatCh) at safe light intensities. High-level CatCh expression was achieved due to a new promoter based on the regulatory region of the gamma-synuclein gene (SNCG) allowing strong expression in ganglion cells across species. Our promoter, in combination with clinically proven adeno-associated virus 2 (AAV2), provides CatCh expression in peri-foveolar ganglion cells responding robustly to light under the illumination safety thresholds for the human eye. On the contrary, the threshold of activation and the proportion of unresponsive cells were much higher when a ubiquitous promoter (cytomegalovirus [CMV]) was used to express CatCh. The results of our study suggest that the inclusion of optimized promoters is key in the path to clinical translation of optogenetics.

Suggestions

Du même auteur

Optogenetic therapy: high spatiotemporal resolution and pattern discrimination compatible with vision restoration in non-human primates

Archive ouverte | Gauvain, Gregory | CCSD

International audience. Vision restoration is an ideal medical application for optogenetics, because the eye provides direct optical access to the retina for stimulation. Optogenetic therapy could be used for diseas...

Targeting Channelrhodopsin-2 to ON-bipolar Cells With Vitreally Administered AAV Restores ON and OFF Visual Responses in Blind Mice

Archive ouverte | Macé, Emilie | CCSD

International audience. Most inherited retinal dystrophies display progressive photoreceptor cell degeneration leading to severe visual impairment. Optogenetic reactivation of retinal neurons mediated by adeno-assoc...

Noninvasive gene delivery to foveal cones for vision restoration

Archive ouverte | Khabou, Hanen | CCSD

International audience. Intraocular injection of adeno-associated viral (AAV) vectors has been an evident route for delivering gene drugs into the retina. However, gaps in our understanding of AAV transduction patte...

Chargement des enrichissements...